MedTrace Logo

Peer-Led Intervention To Reduce Alcohol Binge Drinking Among University Students In Romania

NCT07193030 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-10-01

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a behavioural intervention to change binge drinking habits in university students in Romania is feasible. The main research question is:

Is a peer-led Alcohol Brief Intervention feasible to be implemented in a Romanian University to reduce binge drinking among students?

Researchers will compare brief intervention (counselling) to no intervention.

Student participants will:

1. Receive brief counselling for 15-20 minutes by their peers who were trained.
2. Report their alcohol consumption levels in three surveys conducted over three months.

Conditions

  • Binge Alcohol Consumption
  • Binge Drinking

Interventions

BEHAVIORAL

Peer-led Alcohol Brief Intervention (identification + advice)

The intervention consists of a peer-led ABI for university students. This intervention aligns with the ABI approach recommended by the WHO as a cost-effective strategy to reduce harmful alcohol use, particularly in primary care and community settings. The brief advice component of the intervention will incorporate Motivational Interviewing (MI) techniques, a client-centred, evidence-based counselling style intervention effective for reducing risky drinking behaviours. The brief advice will be tailored based on behavioural insights identified through formative research, such as individual perceived facilitators and barriers. The Alcohol Use Disorders Identification Test- Consumption (AUDIT-C) will be used as the screening tool for identification. A one-on-one Brief Advice sessions of 15-20 minutes will be delivered by trained peer educators, i.e., university students who are not healthcare professionals but have been specifically trained in delivering brief advice.

Sponsors & Collaborators

  • Horizon 2020 - European Commission

    collaborator OTHER

  • International Agency for Research on Cancer

    lead OTHER

Principal Investigators

  • Rubana Islam, PhD · IARC

  • Carolina Espina, PhD · IARC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-07-30
Completion
2026-10-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07193030 on ClinicalTrials.gov